Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model

Journal of Neuroscience

Volumn 22, Issue 23, 2002, Pages 10291-10301

  Ruscher, Karsten ^a   Freyer, Dorette ^a   Karsch, Maria ^a   Isaev, Nikolai ^b   Megow, Dirk ^a   Sawitzki, Birgit ^a   Priller, Josef ^a   Dirnagl, Ulrich ^a   Meisel, Andreas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Astrocyte; Bad; Hypoxia inducible factor 1; Ischemic preconditioning; Janus kinase 2; Neuron; Oxygen glucose deprivation; Phosphoinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CONTROLLED STUDY; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RNA TRANSCRIPTION;

EID: 0036896201     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-23-10291.2002     Document Type: Article

References (62)

1. Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST (1999) Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93:3757-3773.
2. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48:285-296.
3. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651.
4. Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, Mackenzie ET, Petit E (2000) Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30:271-278.
5. Blondeau N, Widmann C, Lazdunski M, Heurteaux C (2001) Activation of the nuclear factor-κB is a key event in brain tolerance. J Neurosci 21:4668-4677.
6. Brewer GJ (1995) Serum-free B27/Neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 42:674-683.
7. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531.
8. Bromberg JF (2001) Activation of STAT proteins and growth control. BioEssays 23:161-169.
9. Bruer U, Weih M, Isaev N, Meisel A, Ruscher K, Bergk A, Trendelenburg G, Wiegand F, Victorov I, Dirnagl U (1997) Induction of tolerance in rat cortical neurons: Hypoxic preconditioning. FEBS Lett 414:117-121.
10. Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, Buemi M (2000) Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 401:349-356.
11. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
12. Constantinescu SN, Huang LJ, Nam H, Lodish HF (2001) The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell 7:377-385.
13. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
14. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
15. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
16. Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signaling cascades. Nature 412:641-647.
17. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717-3720.
18. Fruman DA, Meyers RE, Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67:481-507.
19. Furuya K, Ginis I, Takeda H, Chen Y, Hallenbeck JM (2001) Cell-permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance in ischemia. J Cereb Blood Flow Metab 21:226-232.
20. Ras/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97:436-441.
21. Grabb MC, Choi DW (1999) Ischemic tolerance in murine cortical cell culture: Critical role for NMDA receptors. J Neurosci 19:1657-1662.
22. L: A little bit of this and a little bit of STAT. Curr Opin Oncol 12:543-549.
23. Herlaar E, Brown Z (1999) p38 MAPK signaling cascades in inflammatory disease. Mol Med Today 5:439-447.
24. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 92:4666-4670.
25. Juul SE, Anderson DK, Li Y, Christensen RD (1998) Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43:40-49.
26. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T (1990) "Ischemic tolerance" phenomenon found in the brain. Brain Res 528:21-24.
27. Koh JY, Choi DW (1987) Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83-90.
28. Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T (1993) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 609:29-35.
29. Lawson AE, Bao H, Wickrema A, Jacobs-Helber SM, Sawyer ST (2000) Phosphatase inhibition promotes anti-apoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells. Blood 96:2084-2092.
30. Liu C, Shen K, Liu Z, Noguchi CT (1997) Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272:32395-32400.
31. Liu J, Ginis I, Spatz M, Hallenbeck JM (2000) Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-α and ceramide. Am J Physiol Cell Physiol 278:C144-C153.
32. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M (1996) Erythropoietin gene expression in human, monkey, and murine brain. Eur J Neurosci 8:666-676.
33. Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, Trentz O, Bauer C (1997) Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain. Kidney Int 51:416-418.
34. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas Jr F, Tabira T, Sasaki R (1993) Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268:11208-11216.
35. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269:19488-19493.
36. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
37. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G (2000) Do transient ischemic attacks have a neuroprotective effect? Neurology 54:2089-2094.
38. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105-116.
39. Murata S, Usuda N, Okano A, Kobayashi S, Suzuki T (2000) Occurrence of a transcription factor, signal transducer and activators of transcription 3 (STAT3) in the postsynaptic density of the rat brain. Brain Res Mol Brain Res 78:80-90.
40. Oda A, Sawada K, Druker BJ, Ozaki K, Takano H, Koizumi K, Fukada Y, Handa M, Koike T, Ikeda Y (1998) Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood 92:443-451.
41. Perez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ (1997) Rapid preconditioning protects rats against ischemic neuronal damage after 3, but not 7, days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab 17:175-182.
42. ATP channels. J Cereb Blood Flow Metab 19:1296-1308.
43. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, Scharff A, Dirnagl U, Meisel A (2002) Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22:520-525.
44. Ravati A, Ahlemeyer B, Becker A, Klumpp S, Krieglstein J (2001) Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-κB. J Neurochem 78:909-919.
45. Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
46. Ruscher K, Isaev N, Trendelenburg G, Weih M, Iurato L, Meisel A, Dirnagl U (1998) Induction of hypoxia-inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett 254:117-120.
47. Ruscher K, Reuter M, Kupper D, Trendelenburg G, Dirnagl U, Meisel A (2000) A fluorescence-based nonradioactive electrophoretic mobility shift assay. J Biotechnol 78:163-170.
48. Sadamoto Y, Igase K, Sakanaka M, Sato K, Otsuka H, Sakaki S, Masuda S, Sasaki R (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253:26-32.
49. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95:4635-4640.
50. Semenza GL (2000) HIF-1 mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474-1480.
51. Shamloo M, Rytter A, Wieloch T (1999) Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 93:81-88.
52. L through STAT5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 274:22165-22169.
53. Sinor AD, Greenberg DA (2000) Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 290:213-215.
54. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044-4049.
55. L induction. Cell 98:181-191.
56. Sui X, Krantz SB, Zhao ZJ (2000) Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signaling pathways. Br J Haematol 110:63-70.
57. Wang X, Li X, Erhardt JA, Barone FC, Feuerstein GZ (2000) Detection of tumor necrosis factor-α mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction. J Cereb Blood Flow Metab 20:15-20.
58. Weih M, Harms L, Dirnagl U, Kallenberg K, Einhaupl KM (1999) Attenuated stroke severity after prodromal TIA: A role for ischemic tolerance in the brain? Stroke 30:1851-1854.
59. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236.
60. Yamaguchi A, Tamatani M, Matsuzaki H, Namikawa K, Kiyama H, Vitek MP, Mitsuda N, Tohyama M (2001) Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem 276:5256-5264.
61. waf1/cip1, and erythropoietin. J Neurosci 19:9821-9830.
62. L. Cell 87:619-628.